Literature DB >> 18774003

Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns.

Steven E Lipshultz1, Valeriano C Simbre, Sema Hart, Nader Rifai, Stuart R Lipsitz, Linda Reubens, Robert A Sinkin.   

Abstract

Myocardial damage in infancy is a risk factor for eventual cardiac disease. Given that myocardial stress is greatest during the perinatal period and that the neonatal period is when most pediatric heart failure occurs, the aim of this study was to determine whether even otherwise healthy neonates might have subclinical myocardial damage and, if so, what characteristics might identify them. Umbilical cord and neonatal serum samples from 32 normal neonates were assayed for biomarkers of myocardial injury. No neonate had clinical evidence of cardiac or other abnormalities. Serum cardiac troponin T was elevated in 19 of 25 cords (76%) and in 16 of 17 neonates (94%); levels indicating myocardial infarction (> or =0.2 ng/ml) were found in 2 patients (1 umbilical cord and 1 neonatal sample). Creatine kinase-MB was elevated in 6 of 16 cords (38%) and in 8 of 15 neonates (53%). Cardiac troponin I was elevated in 11% and 17% of samples, myoglobin in 4% and 17%, and high-sensitivity C-reactive protein in 9% and 40%. Measures of myocardial injury were associated with longer hospitalization (r = 0.50, p = 0.04), non-Caucasian race (p = 0.012), lower birth weights (p = 0.014), positive maternal cervical cultures (r = 0.41, p = 0.046), and elevated high-sensitivity C-reactive protein (r = 0.66, p = 0.005). In conclusion, clinically occult myocardial injury appears to occur in some healthy newborns, although whether it is pathologic or not remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774003      PMCID: PMC2640933          DOI: 10.1016/j.amjcard.2008.04.057

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Cardiac troponin I and N-terminal pro-brain natriuretic peptide in umbilical artery blood in relation to fetal heart rate abnormalities during labor.

Authors:  S M Fleming; T O'Gorman; L O'Byrne; H Grimes; K M Daly; J J Morrison
Journal:  Pediatr Cardiol       Date:  2001 Sep-Oct       Impact factor: 1.655

2.  Fetal cardiac troponin I in relation to intrapartum events and umbilical artery pH.

Authors:  Fionnuala McAuliffe; Katrina Mears; Sean Fleming; Helen Grimes; John J Morrison
Journal:  Am J Perinatol       Date:  2004-04       Impact factor: 1.862

3.  Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).

Authors:  Per Venge; B o Lagerqvist; Erik Diderholm; Bertil Lindahl; Lars Wallentin
Journal:  Am J Cardiol       Date:  2002-05-01       Impact factor: 2.778

4.  Subclinical myocardial injury in small-for-gestational-age neonates.

Authors:  T Chaiworapongsa; J Espinoza; J Yoshimatsu; K Kalache; S Edwin; S Blackwell; B H Yoon; J E Tolosa; M Silva; E Behnke; R Gomez; R Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2002-06

5.  The effect of gestational age, birth weight, and disease on troponin I and creatine kinase MB in the first year of life.

Authors:  E S Quivers; J N Murthy; S J Soldin
Journal:  Clin Biochem       Date:  1999-08       Impact factor: 3.281

6.  The incidence of pediatric cardiomyopathy in two regions of the United States.

Authors:  Steven E Lipshultz; Lynn A Sleeper; Jeffrey A Towbin; April M Lowe; E John Orav; Gerald F Cox; Paul R Lurie; Kristina L McCoy; Melissa A McDonald; Jane E Messere; Steven D Colan
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study.

Authors:  Steven E Lipshultz; Kirk A Easley; E John Orav; Samuel Kaplan; Thomas J Starc; J Timothy Bricker; Wyman W Lai; Douglas S Moodie; George Sopko; Mark D Schluchter; Steven D Colan
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

8.  Cardiac troponin I, cardiac troponin T and creatine kinase MB concentrations in umbilical cord blood of healthy term neonates.

Authors:  D Trevisanuto; M Pitton; S Altinier; M Zaninotto; M Plebani; V Zanardo
Journal:  Acta Paediatr       Date:  2003-12       Impact factor: 2.299

9.  Associations between neurohormonal and inflammatory activation and heart failure in children.

Authors:  Christopher Ratnasamy; Daniel D Kinnamon; Steven E Lipshultz; Paolo Rusconi
Journal:  Am Heart J       Date:  2008-03       Impact factor: 4.749

10.  Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children.

Authors:  J Soongswang; K Durongpisitkul; S Ratanarapee; W Leowattana; A Nana; D Laohaprasitiporn; S Akaniroj; N Limpimwong; C Kangkagate
Journal:  Pediatr Cardiol       Date:  2002 Sep-Oct       Impact factor: 1.655

View more
  10 in total

1.  Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Authors:  Steven E Lipshultz; William T Shearer; Bruce Thompson; Kenneth C Rich; Irene Cheng; E John Orav; Sulekha Kumar; Ricardo H Pignatelli; Louis I Bezold; Philip LaRussa; Thomas J Starc; Julie S Glickstein; Sharon O'Brien; Ellen R Cooper; James D Wilkinson; Tracie L Miller; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

2.  Cardiac myocyte proliferation and maturation near term is inhibited by early gestation maternal testosterone exposure.

Authors:  Sonnet S Jonker; Samantha Louey; Charles E Roselli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-10       Impact factor: 4.733

3.  Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.

Authors:  Steven E Lipshultz; Rebecca E Scully; Stuart R Lipsitz; Stephen E Sallan; Lewis B Silverman; Tracie L Miller; Elly V Barry; Barbara L Asselin; Uma Athale; Luis A Clavell; Eric Larsen; Albert Moghrabi; Yvan Samson; Bruno Michon; Marshall A Schorin; Harvey J Cohen; Donna S Neuberg; E John Orav; Steven D Colan
Journal:  Lancet Oncol       Date:  2010-09-16       Impact factor: 41.316

4.  Cardiac biomarkers in HIV-exposed uninfected children.

Authors:  James D Wilkinson; Paige L Williams; Erin Leister; Bret Zeldow; William T Shearer; Steven D Colan; George K Siberry; Laurie B Dooley; Gwendolyn B Scott; Kenneth C Rich; Steven E Lipshultz
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

Review 5.  Clinical research directions in pediatric cardiology.

Authors:  Steven E Lipshultz; James D Wilkinson; Sarah E Messiah; Tracie L Miller
Journal:  Curr Opin Pediatr       Date:  2009-10       Impact factor: 2.856

Review 6.  Cardiac injury biomarkers in paediatric age: Are we there yet?

Authors:  Ana L Neves; Tiago Henriques-Coelho; Adelino Leite-Moreira; José C Areias
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

7.  Cardiac Troponin T in Healthy Full-Term Infants.

Authors:  Jonna Karlén; Mathias Karlsson; Håkan Eliasson; Anna-Karin Edstedt Bonamy; Cecilia Pegelow Halvorsen
Journal:  Pediatr Cardiol       Date:  2019-09-05       Impact factor: 1.655

Review 8.  Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.

Authors:  David T Paik; Mark Chandy; Joseph C Wu
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

9.  Cardiac troponin T levels of umbilical cord in neonates with abnormal fetal heart rate.

Authors:  Rafati Shiva; Rabi Maryam; Borna Hajie
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364

10.  Increased left ventricular posterior wall end-diastolic thickness in adolescents with delayed diagnosis of vertically acquired HIV infection.

Authors:  Robert F Miller; Jamilah Meghji; Juan P Kaski; Jonathan Matenga; Rashida A Ferrand
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.